Farletuzumab (MORAb-003) is a potent inhibitor of folate receptor-alpha (FRalpha). Farletuzumab is a humanized monoclonal antibody with a high affinity for FRalpha. Farletuzumab inhibits the growth of cells that overexpress FRalpha. Farletuzumab can be used to study can
CAS Number:
[896723-44-7]
Target:
Antifolate
* VAT and and shipping costs not included. Errors and price changes excepted